| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 22 |
| 1 | ETONOGESTREL AND ETHINYL ESTRADIOL | 19 |
| 2 | LEVONORGESTREL | 19 |
| 3 | ACETAMINOPHEN | 11 |
| 4 | NATALIZUMAB | 11 |
| 5 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 10 |
| 6 | METHOTREXATE SODIUM | 10 |
| 7 | METHOTREXATE | 9 |
| 8 | ARIPIPRAZOLE | 7 |
| 9 | CELECOXIB | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPROPION HCL ER | 1 | 0.0021 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 | 0.0011 |
| 2 | ETONOGESTREL AND ETHINYL ESTRADIOL | 19 | 0.0009 |
| 3 | RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE | 1 | 0.0007 |
| 4 | PERMETHRIN | 1 | 0.0006 |
| 5 | AZATHIOPRINE SODIUM | 1 | 0.0004 |
| 6 | SELEGILINE | 1 | 0.0003 |
| 7 | IBANDRONATE SODIUM | 1 | 0.0003 |
| 8 | LEUCOVORIN CALCIUM | 6 | 0.0003 |
| 9 | DESOGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 41 |
| 1 | Estrogen [EPC] | 20 |
| 2 | Progestin-containing Intrauterine System [EPC] | 19 |
| 3 | Integrin Receptor Antagonist [EPC] | 14 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 6 | Corticosteroid [EPC] | 10 |
| 7 | Expectorant [EPC] | 10 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 9 |
| 9 | Vitamin D [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyrethroid [EPC] | 1 | 0.0006 |
| 1 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 3 | Integrin Receptor Antagonist [EPC] | 14 | 0.0002 |
| 4 | Progestin [EPC] | 41 | 0.0001 |
| 5 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 7 | Estrogen [EPC] | 20 | 0.0001 |
| 8 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 9 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |